TAFINLAR (Dabrafenib) Capsules

What is Tafinlar (Dabrafenib)
Tafinlar is a cancer medication that interferes with the growth and spread of cancer cells in the body. Tafinlar is used to treat a certain type of metastatic melanoma ( skin cancer that has spread to other parts of the body)


Drug Manufacturer / Marketeer :

M/s GlaxoSmithKline

Available as:

50 mg and 70mg capsules

Tafinlar is indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA approved test.

For treatment related information, please consult your treating Physician.

How supplied:

  • Tafinlar 50 mg (dark red capsule) is supplied in bottles of 120.
  • Tafinlar 75 mg (dark pink capsule) is supplied in bottles of 120.

Storage and handling:
Store at 20°- 25° C, excursions permitted to 15° to 30° C.

How do we source the Drug?
SMIQ Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.

Company that Manufactures/ Markets:
M/s GlaxoSmithKline .

Assistance Cell in India:
For ONCOLOGY DRUG: TAFINLAR (Dabrafenib) Capsules 50MG and 70MG price.

Contact us @ +91 7678048225 or by email  info@smiqpharma.com.